YARW
Yarrow BioscienceFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Composite grade F from latest DB weights. Momentum 5.5 / Value 40.6
Posture
Defensive
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-11-04.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
5
Value
41
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -Analysis date unavailable; returns require an exact persisted reference.
Earnings
2026-11-04
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-27 • Vendor: Data Vendor v1
Scores
As of 2026-10-28 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-10-28
Investment thesis
As of 2026-10-28
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-28. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $57.00
Why
Momentum5 · Δ7d +1.8
Value41 · Δ7d -0.1
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Next scheduled catalyst: earnings 2026-11-04.
- • Value remains the lead driver in the composite, 7D delta -0.1.
Contradictions & invalidation
- • Mixed signals. Wait for cleaner trend confirmation.
Catalyst clock
2026-11-04
Lead driver: Value · See fundamentals
Momentum
5
15% active weight
Current posture
7d trendImproving
Δ7d
+1.8
Δ21d
-1.9
Value
41
85% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.3
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 5.5 / Value 40.6
Fundamentals (TTM)As of 2026-10-27
Fundamentals (TTM)
As of 2026-10-27
Market Cap
$189.89M
Beta
2.02
Shares Out
9.44M
P/E (TTM) · Derived
-0.6
P/S (TTM)
35.88
P/FCF (TTM) · Derived
-0.96
Rev YoY
+40.6%
EPS YoY
-47.9%
Gross Margin
+95.2%
Op Margin
-4134.6%
Net Debt
-$29.01M
Current Ratio
15.26
As of 2026-10-28 • Updated nightlySource: Internal modelMethods & Data